Repare Therapeutics (RPTX)

• Market cap: $56.1M
• 1 day: 0.00%
• 5 days: -27.47%
• 1 month: -53.52%
• 3 months: -62.50%
• 6 months: -62.50%
• Year to date: -81.89%
• 1 year: -79.66%
• 5 years: -95.71%
• 10 years: -95.71%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

Employees: 179

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more call options, than puts

Call options by funds: $3K | Put options by funds: $1K

1% less capital invested

Capital invested by funds: $113M [Q2] → $111M (-$1.15M) [Q3]

4.0% less ownership

Funds ownership: 80.29% [Q2] → 76.29% (-4.0%) [Q3]

8% less funds holding

Funds holding: 61 [Q2] → 56 (-5) [Q3]

17% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 18

50% less funds holding in top 10

Funds holding in top 10: 4 [Q2] → 2 (-2) [Q3]

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $4 203% upside
• Avg. target: $7 430% upside
• High target: $10 658% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Stifel Benjamin Burnett 36% 1-year accuracy 5 / 14 met price target	203% upside $4	Buy Maintained	13 Dec 2024
HC Wainwright & Co. Robert Burns 23% 1-year accuracy 36 / 155 met price target	658% upside $10	Buy Reiterated	8 Nov 2024